Breast Cancer
Showing NaN - NaN of 143
Organoid Model Predictive of Response to Immunotherapies
Recruiting
- Breast Cancer
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 10, 2023
Breast Cancer Trial in United States (carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, vorinostat)
Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)
Completed
- Breast Cancer
- Stage IV Breast Cancer
- palliative surgery
- +3 more
-
Mobile, Alabama
- +376 more
Jan 6, 2023
Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)
Active, not recruiting
- Breast Cancer
- Positron emission tomography (PET)
- +2 more
-
Birmingham, Alabama
- +9 more
Jan 20, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)
Recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Capecitabine
- +4 more
-
Washington, District of Columbia
- +5 more
Jan 12, 2023
HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer Trial in United States (Pertuzumab+TRASTUZUMAB,
Recruiting
- HER2-positive Breast Cancer
- +5 more
- Pertuzumab+TRASTUZUMAB
- ADJUVANT ENDOCRINE THERAPY
-
Stamford, Connecticut
- +21 more
Dec 12, 2022
Breast Cancer Trial in Worldwide (Olaparib, Placebo)
Breast Cancer, Cognitive Change, Cognitive Impairment Trial in Indianapolis (Sweep Seeker, Bird Safari, Jewel Diver)
Completed
- Breast Cancer
- +3 more
- Sweep Seeker
- +5 more
-
Indianapolis, IndianaIndiana University School of Nursing
Oct 4, 2022
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Malignant Tumor of Breast, Breast Cancer Trial in United States (Genomically Directed Monotherapy, Observation/Standard Therapy)
Active, not recruiting
- Malignant Neoplasm of Breast
- Breast Cancer
- Genomically Directed Monotherapy
- Observation/Standard Therapy
-
Birmingham, Alabama
- +28 more
Aug 30, 2022
Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)
Breast Tumor, Breast Cancer, Breast Carcinoma Trial in Indianapolis (Enhanced Usual Care, Acceptance Commitment Therapy,
Recruiting
- Breast Neoplasm
- +11 more
- Enhanced Usual Care
- +2 more
-
Indianapolis, IndianaIndiana University-Purdue University Indianapolis
Jul 23, 2022
Breast Cancer, Indolent Metastatic Breast Cancer Trial in Avon, Carmel, Indianapolis (Exercise Intervention)
Not yet recruiting
- Breast Cancer
- Indolent Metastatic Breast Cancer
- Exercise Intervention
-
Avon, Indiana
- +3 more
Jul 18, 2022
Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)
Active, not recruiting
- Breast Cancer
- therapeutic conventional surgery
- whole breast irradiation
-
Hot Springs, Arkansas
- +349 more
Jun 16, 2022
Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)
Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Breast Cancer Trial in United States (Trastuzumab, Paclitaxel, Trastuzumab emtansine)
Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)
Terminated
- Triple-Negative Breast Neoplasms
- +3 more
- Trilaciclib
- +2 more
-
Tucson, Arizona
- +53 more
Feb 24, 2022
Breast Cancer Trial in United States (Palbociclib, Aromatase Inhibitor)
Completed
- Breast Cancer
- Palbociclib
- Aromatase Inhibitor
-
San Francisco, California
- +9 more
Mar 18, 2022
Breast Cancer Trial in United States (Neratinib, Fulvestrant)
Active, not recruiting
- Breast Cancer
-
Indianapolis, Indiana
- +5 more
Mar 2, 2022